Creative Capital Management Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History

Creative Capital Management Investments’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$299	Buy	+8	New	+$297	﹤0.01%	1358

Other funds holding CRNX

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Lewis Asset Management Lafayette, California $285M AUM 32.52% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Creative Capital Management Investments's CRNX Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Crinetics Pharmaceuticals (CRNX) in Q2 2026: 8 shares worth $299. The stake represents ﹤0.01% of the portfolio and ranks #1358 among its holdings.

32 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

Creative Capital Management Investments held 8 shares of Crinetics Pharmaceuticals worth $299 as of Q2 2026.
Crinetics Pharmaceuticals was a new Creative Capital Management Investments position in Q2 2026.
Crinetics Pharmaceuticals made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1358 holding.
32 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.